NCT00586547View on ClinicalTrials.gov

Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
LeukemiaCancer
Interventions
BIOLOGICAL

T-Cell Infusion Dose Level -1

(1 x 10\^3 T cells/Kg)

BIOLOGICAL

T-Cell Infusion Dose Level 1

(1 x 10\^4 T cells/Kg)

BIOLOGICAL

T-Cell Infusion Dose Level 2

(1 x 10\^5 T cells/Kg)

BIOLOGICAL

T-Cell Infusion Dose Level 3

(1 x 10\^6 T cells/Kg)

BIOLOGICAL

T-Cell Infusion- Dose Level 4

(5 x 10\^6 T cells/Kg)

Trial Locations (2)

77030

Methodist Hospital, Houston

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

lead

Baylor College of Medicine

OTHER

NCT00586547 - Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation | Biotech Hunter | Biotech Hunter